Motesanib Diphosphate
產品名稱:Motesanib Diphosphate
產品描述:
產品描述 | Motesanib Diphosphate is the orally bioavailable diphosphate salt of a multiple-receptor tyrosine kinase inhibitor with potential antineoplastic activity. |
靶點活性 | Kit:8 nM, VEGFR2/Flk1:6 nM, VEGFR1:2 nM, VEGFR3:6 nM, VEGFR2:3 nM |
體外活性 | 在大鼠角膜模型中,每天口服兩次(ED50=2.1 mg/kg )或一次(ED50=4.9 mg/kg )Motesanib Diphosphate能夠抑制血管內皮生長因子誘導的血管生成.在頭部和頸部鱗狀細胞癌移植瘤模型中,Motesanib Diphosphate和輻射治療聯用,顯示出顯著地抗癌活性. |
體內活性 | 在VEGF誘導的HUVECs細胞中(IC50 =10 nM),Motesanib Diphosphate 明顯抑制細胞增殖。對于血小板衍生因子誘導的增殖(IC50=207 nM)和SCF誘導的c-kit磷酸化(IC50=37 nM),Motesanib Diphosphate能夠顯著抑制。人臍靜脈內皮細胞,Motesanib Diphosphate增強細胞對于放射性的敏感程度。對人VEGFR家族,Motesanib Diphosphate具有廣譜活性。 |
激酶實驗 | In vitro kinase assays: Optimal enzyme, ATP, and substrate (gastrin peptide) concentrations are established for each enzyme using homogeneous time-resolved fluorescence (HTRF) assays. Motesanib Diphosphate is tested in a 10-point dose-response curve for each enzyme using an ATP concentration of two-thirds Km for each. Most assays consist of enzyme mixed with kinase reaction buffer [20 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 5 mM MnCl2, 100 mM NaCl, 1.5 mM EGTA]. A final concentration of 1 mM DTT, 0.2 mM NaVO4, and 20 μg/mL BSA is added before each assay. For all assays, 5.75 mg/mL streptavidin-allophycocyanin and 0.1125 nM Eu-PT66 are added immediately before the HTRF reaction. Plates are incubated for 30 minutes at room temperature and read on a Discovery instrument. IC50 values are calculated using the Levenberg-Marquardt algorithm into a four-parameter logistic equation. |
細胞實驗 | Cells are preincubated for 2 hours with different concentrations of Motesanib Diphosphate, and exposed with 50 ng/mL VEGF or 20 ng/mL bFGF for an additional 72 hours. Cells are washed twice with DPBS, and plates are frozen at -70 °C for 24 hours. Proliferation is assessed by the addition of CyQuant dye, and plates are read on a Victor 1420 workstation. IC50 data are calculated using the Levenberg-Marquardt algorithm into a four-parameter logistic equatio(Only for Reference) |
別名 | Motesanib, 二磷酸莫替沙尼, AMG 706 |
分子量 | 569.448 |
分子式 | C22H29N5O9P2 |
CAS No. | 857876-30-3 |
存儲
| Powder: -20°C for 3 years | In solvent: -80°C for 2 years
溶解度
H2O: 16 mg/mL (28.1 mM)
Ethanol: <1 mg/mL
DMSO: 93 mg/mL (163.3 mM)
( < 1 mg/mL refers to the product slightly soluble or insoluble )
聯系我們:
郵箱:2519696869@qq.com
QQ: 2519696869
電話:18066853083
微信:18066853083
公司介紹:
西安齊岳生物科技有限公司是集化學科研和定制與一體的高科技化學公司。業務范圍包括化學試劑和產品的研發、生產、銷售等。涉及產品為通用試劑的分銷、非通用試劑的定制與研發,涵蓋生物科技、化學品、中間體和化工材料等領域。
主營產品:COF、MOF單體系列:三蝶烯衍生物、金剛烷衍生物、四苯甲烷衍生物、peg、上轉換、石墨烯、光電材料、點擊化學、凝集素、載玻片、蛋白質交聯劑、脂質體、蛋白、多肽、氨基酸、糖化學等。